Biology of the Blood-Testis Barrier
血睾屏障的生物学
基本信息
- 批准号:8613215
- 负责人:
- 金额:$ 39.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:Actin-Binding ProteinActinsAcuteAddressAdherens JunctionAdhesivesApicalBasement membraneBiologicalBiologyBloodBlood-Testis BarrierBundlingCadmiumCell AdhesionCell membraneCollagenComplexContraceptive AgentsDeveloped CountriesDeveloping CountriesDevelopmentDiethylstilbestrolDoseEndoplasmic ReticulumEndosomesEpidermal Growth Factor Receptor Pathway Substrate 8EpithelialEpitheliumEventF-ActinFertilityFunctional disorderGelatinase AGelatinase BGenerationsGenesGenetic ModelsGrantHomeostasisIn VitroIntercellular JunctionsJournalsKnock-outLaboratoriesLamininLeadLiftingLightMale Contraceptive AgentsMale InfertilityMammalsMediatingMeiosisMetalloproteasesMicroRNAsMicrofilamentsMolecularMusNatureNeonatalNeuronsPeer ReviewPeptidesProductionProteinsPublicationsRNA InterferenceRattusRegulationResearchResearch PersonnelRodentRoleSeminiferous tubule structureSmall Interfering RNASmall RNASpermatidsSpermatocytesSpermatogenesisStagingSteroidsStructureTechniquesTestisTestosteroneTissuesToxic Environmental SubstancesTrainingWiskott-Aldrich Syndromeautocrinebisphenol Acytokinedesigngenetic regulatory proteinin vivoinsightmalemennovelnovel therapeutic interventionoverexpressionphthalatespiRNApolymerizationprotein transportpublic health relevancereproductiveresearch studysertoli cellsmall moleculespatiotemporalsperm cellspermatogenic epithelium structuretherapeutic developmenttoxicantxenoestrogen
项目摘要
Project Summary/Abstract. In the mammalian testis, spermatogenesis takes place in the epithelium of the
seminiferous tubule, the functional unit that produces millions of spermatozoa daily. The blood-testis barrier
(BTB), located near the basement membrane (BM) of the seminiferous epithelium, confers gate-keeper and
the fence function, which restricts the paracellular and transcellular transport of harmful substances such as
toxicants across the barrier, respectively, to maintain spermatogenesis. The BTB also physically divides the
seminiferous epithelium into a basal and an adluminal compartment; thus, meiosis I and II, and post-meiotic
spermatid development take place in a specialized microenvironment (i.e., the adluminal compartment)
behind the BTB. The BTB is one of the tightest blood-tissue barriers in mammals since cell junctions at the
BTB are reinforced by bundles of actin filaments that lie perpendicular to apposing Sertoli cell plasma
membranes, which are only found in the testis. However, the BTB is a dynamic structure, undergoing
extensive restructuring at stage VIII of the epithelial cycle so that preleptotene spermatocytes can cross the
BTB and enter the adluminal compartment for further development. It is now well established that a
functional BTB is crucial for spermatogenesis. Studies completed in the past grant period have shown that
BTB function is regulated by biologically active peptides released (i) at the apical ectoplasmic specialization
(apical ES, a testis-specific adherens junction at the Sertoli-spermatid interface), and (ii) at the basement
membrane (BM) mediated by a functional axis designated the apical ES-BTB-BM axis. In short, biologically
active fragments of laminin and collagen chains released at the apical ES and the BM, respectively, act as
autocrine factors to regulate BTB function in this axis. Herein, we will continue this important research to
understand the underlying molecular mechanism(s) that regulates BTB function. First, we will unravel the
mechanism(s) by which these fragments regulate Sertoli cell adhesion and BTB restructuring via their effects
on the F-actin network at the BTB, such as actin binding and regulatory proteins. We will also examine the
involvement of endosome-mediated protein trafficking and small regulatory RNAs in these events using
state-of-the-art techniques and approaches. Second, we will identify the biological significance of
biomolecules, such as cytokines, steroids and matrix metalloproteases, in regulating the stage-specific
production of these bioactive peptides during the epithelial cycle of spermatogenesis. These findings will
have a significant impact in understanding the biology of BTB in spermatogenesis. More important, these
findings will shed new light on the development of novel reversible non-hormonal contraceptives for men.
For instance, peptides derived from the apical ES and BM can be developed into contraceptives to perturb
BTB function and impair spermatogenesis. Additionally, these findings can lead to the development of new
therapeutic approaches to interfere with toxicant-induced male reproductive dysfunction, which is one of the
leading causes of the decline in male fertility. For instance, the environmental toxicant cadmium mediates its
effects at the BTB to induce male reproductive dysfunction; these findings provide crucial information in the
design and synthesis of small molecules that either reverse or block cadmium-induced BTB disruption that
leads to male infertility.
项目摘要/摘要。在哺乳动物睾丸中,精子发生发生在睾丸上皮细胞中
生精小管,每天产生数百万精子的功能单位。血睾屏障
(BTB)位于生精上皮的基底膜(BM)附近,赋予看门人和
栅栏功能,限制有害物质的细胞旁和跨细胞运输,例如
分别穿过毒物屏障,维持精子发生。 BTB 还在物理上划分了
生精上皮分为基底室和腔室;因此,减数分裂 I 和 II 以及减数分裂后
精子细胞的发育发生在特殊的微环境(即腔内室)中
落后于BTB。 BTB 是哺乳动物中最紧密的血液组织屏障之一,因为
BTB 由垂直于并列支持细胞血浆的肌动蛋白丝束增强
膜,仅存在于睾丸中。然而,BTB 是一个动态结构,不断变化
在上皮周期的第八阶段进行广泛的重组,以便前细线精母细胞可以穿过
BTB 并进入腔室进一步发育。现在已经确定的是
功能性 BTB 对于精子发生至关重要。在过去的资助期内完成的研究表明
BTB 功能受到顶端外质特化释放的生物活性肽的调节 (i)
(顶端 ES,支持精子细胞界面处的睾丸特异性粘附连接),以及 (ii) 基底
膜(BM)由称为顶端 ES-BTB-BM 轴的功能轴介导。简而言之,从生物学角度来说
层粘连蛋白和胶原链的活性片段分别在顶端 ES 和 BM 释放,充当
自分泌因子调节该轴的 BTB 功能。在此,我们将继续这项重要的研究
了解调节 BTB 功能的潜在分子机制。首先,我们将解开
这些片段通过其作用调节支持细胞粘附和 BTB 重组的机制
BTB 上的 F-肌动蛋白网络,例如肌动蛋白结合蛋白和调节蛋白。我们还将检查
内体介导的蛋白质运输和小调节 RNA 在这些事件中的参与
最先进的技术和方法。其次,我们要明确其生物学意义。
生物分子,如细胞因子、类固醇和基质金属蛋白酶,在调节特定阶段
这些生物活性肽在精子发生的上皮周期中产生。这些发现将
对于了解 BTB 在精子发生中的生物学具有重大影响。更重要的是,这些
研究结果将为新型可逆男性非激素避孕药的开发提供新的线索。
例如,源自顶端ES和BM的肽可以开发成避孕药来扰乱
BTB 功能并损害精子发生。此外,这些发现可能会导致新的开发
干扰毒物引起的男性生殖功能障碍的治疗方法,这是治疗方法之一
男性生育能力下降的主要原因。例如,环境毒物镉介导其
BTB 的影响会导致男性生殖功能障碍;这些发现提供了重要信息
设计和合成小分子,逆转或阻止镉诱导的 BTB 破坏
导致男性不育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
C. Yan Cheng其他文献
C. Yan Cheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('C. Yan Cheng', 18)}}的其他基金
An in vivo model to study blood-testis barrier dynamics
研究血睾屏障动力学的体内模型
- 批准号:
7485598 - 财政年份:2007
- 资助金额:
$ 39.41万 - 项目类别:
An in vivo model to study blood-testis barrier dynamics
研究血睾屏障动力学的体内模型
- 批准号:
7305201 - 财政年份:2007
- 资助金额:
$ 39.41万 - 项目类别:
相似国自然基金
WDR1介导的肌动蛋白解聚动态平衡在小脑浦肯野细胞衰老性焦亡中的作用研究
- 批准号:32371053
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肌动蛋白结合蛋白ANLN在胆汁淤积性肝损伤后肝再生过程中的作用及机制研究
- 批准号:82370648
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肌动蛋白成核促进因子SHRC的结构和分子机制的研究
- 批准号:32301034
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肌动蛋白结合蛋白Xirp2介导基质刚度诱导心肌细胞肥大的力学生物学机制
- 批准号:12372314
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
染色质重塑因子肌动蛋白样6A在视网膜变性中的作用机制及干预研究
- 批准号:82371081
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 39.41万 - 项目类别:
Mechanisms of septin-actin cytoskeletal crosstalk
septin-肌动蛋白细胞骨架串扰的机制
- 批准号:
10677181 - 财政年份:2023
- 资助金额:
$ 39.41万 - 项目类别:
Mechanisms of septin-actin cytoskeletal crosstalk
septin-肌动蛋白细胞骨架串扰的机制
- 批准号:
10677181 - 财政年份:2023
- 资助金额:
$ 39.41万 - 项目类别:
Biochemical and cellular mechanisms linking actin mutations to visceral myopathy
将肌动蛋白突变与内脏肌病联系起来的生化和细胞机制
- 批准号:
10363282 - 财政年份:2021
- 资助金额:
$ 39.41万 - 项目类别:
Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure
Lcn10 在脓毒症引起的血管渗漏和心力衰竭中的作用
- 批准号:
10532242 - 财政年份:2021
- 资助金额:
$ 39.41万 - 项目类别: